Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

Abstract

ROC curve analysis can be used as an alternative method in the selection and validation of cut-off scores for determining the clinically relevant threshold for immunohistochemical tumour positivity.